Maxcyte, Inc. (MXCT)
- Sector
- Life Sciences Tools & Services
- Last price
- $0.96
- As of
Kresmion compiles this page from MXCT's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
MAXCYTE, INC. (MXCT): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-14.
See the full MXCT dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for MXCT on one page. Preview it with sample data, then open it live with a free account.
Preview the MXCT dossierActive signals for MXCT
- highCONSENSUS_BUY
5 tracked funds increased MXCT this 2026Q2, institutional consensus
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 16.0%, EPS $-0.08 vs $-0.0952 estimate
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 88% of MXCT (2026Q2)
- highCONSENSUS_BUY
3 tracked funds increased MXCT this 2026Q2, institutional consensus
- highINSTITUTIONAL_SURGE
Point72 Asset Management, L.P. added +182% to MXCT (2026Q2)
FREE, NO ACCOUNT
Every signal on MXCT, as it fires
You are seeing 5 of 16 signals recorded on MXCT since 2026-06-02.
The five above landed across 3 days. The other 11 were recorded on 3 other days. 8 of the 16 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in MXCT (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 57777K106 · 2026Q2 | $2.4M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 57777K106 · 2026Q2 | $1.8M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 57777K106 · 2026Q2 | $1.5M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 57777K106 · 2026Q2 | $1.1M | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 57777K106 · 2026Q2 | $369K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, MXCT
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
MXCT against its peers
MXCT's operating margin of -247.6% ranks in the 19th percentile of 23 Life Sciences Tools & Services sub-industry peers, fiscal periods ending between 2025-10-31 and 2026-06-30.
| Metric | MXCT | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 21.0M USD | 1.2B USD | 10 | 25 |
| Gross margin | 127.9% | 53.7% | 96 | 12 |
| Operating margin | -247.6% | -9.5% | 19 | 23 |
| Net margin | -213.0% | -6.8% | 13 | 25 |
| Return on equity | -26.0% | -7.5% | 34 | 24 |
| P / E | n/a | 45.2x | n/a | 10 |
| 1 year | -39.8% | 27.9% | 6 | 25 |
Peers (25): SEER, CDXS, PACB, OABI, CTKB, MLAB, DNA, MRVI, FTRE, ABCL, ADPT, SHC, BRKR, TXG, AVTR, RGEN, TECH, TEM, CRL, MEDP, MTD, ILMN, WAT, IQV, A. Fiscal periods ending between 2025-10-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (MXCT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow MXCT on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to MXCT for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.